CA-VELODYNE-LIDAR
15.11.2019 17:02:09 CET | Business Wire | Press release
Velodyne Lidar, Inc. today introduced Alpha Prime™, the next generation lidar sensor utilizing Velodyne’s patented surround view technology to deliver the combined highest performance specifications for the autonomous mobility industry in one sensor. The sensor is an unmatched solution in perception, field-of-view and range for autonomous markets including transportation, trucking and robotics. Offering a new level of power efficiency, the Alpha Prime is available now for orders and delivery.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005071/en/
The Alpha Prime’s unique combination of breakthrough innovations allows vehicles to navigate in unfamiliar and dynamic settings. Its best-in-class capabilities help improve vehicle safety and enable more precise mapping. These include:
- Superior field-of-view: 360-degree surround view perception and a 40-degree vertical field-of-view.
- Outstanding performance in a wide variety of lighting conditions, including retro reflectors and sunlight mitigation.
- Exceptional detection of dark or low reflectance objects at long distances, such as tires, dark vehicles, low reflectivity pavement and low visibility pedestrians.
- Advanced negative obstacle perception, such as potholes and cracks in the road.
- The highest resolution along with robust reflectivity returns from over 4.8 million points per second, simplifying detection and tracking of vehicles, pedestrians and other obstructions.
- High resolution and laser calibration enable the sensor to easily localize vehicles — outdoors or indoors — without a GPS, for precise positioning.
- Improved efficiency for extended vehicle operating time within broad temperature and environmental ranges without the need for active cooling.
- Advanced sensor-to-sensor interference mitigation.
- Automotive mass production options from multiple sources for qualified programs.
“Voyage has developed and deployed self-driving cars super-charged by Velodyne’s lidar technology for the past three years,” said Oliver Cameron, Voyage Co-Founder & CEO. “Our team is amazed by the advancements in the Alpha Prime and are continually impressed by Velodyne’s string of innovations.”
“The Alpha Prime is a significant step forward in enabling the advancement of the autonomous vehicle and robot industries,” said Anand Gopalan, Chief Technology Officer, Velodyne Lidar. “With its breadth of best-in-class features, the Alpha Prime is a marked advancement in sensor performance for real world conditions. Here at Velodyne, we take pride in listening to our customers and delivering innovative and high-performance products. We believe Velodyne’s versatility and agility extend our leadership status in the lidar business to empower autonomous solutions on a global scale.”
Velodyne provides world-class technical support for the sensor across North America, Europe, and Asia.
For full product specifications, please visit: https://velodynelidar.com/vls-128.html .
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s Founder and CEO, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™ and the groundbreaking software for driver assistance, Vella™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191115005071/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom